QIAGEN Clinical Insight is an integrated clinical decision support solution designed specifically for routine genomic testing laboratories assessing next-generation sequencing (NGS) data.
With QIAGEN Clinical Insight (QCI™) you can annotate, interpret and report NGS variants in the context of over 5 million relevant biomedical findings while building your own internal experiential knowledge base. QCI allows you to minimize complexity, time, and cost associated with determining clinical significance and action-ability of NGS variants.
Make complexity manageable
The QCI Interpret platform replaces your complex and tedious NGS variant research with a scalable interpretation workflow alternative. QCI can help clinical laboratories interpret co-occurring alterations such as fusions, gene amplifications and deletions, and copy number changes:
Reveal the clinical significance in NGS variants
QCI Interpret offers the most comprehensive content available for biomedical findings on somatic cancer in one easy-to-use user interface. Now with access to over 5 million biomedical findings, QCI is an interpretation productivity tool that helps identify actionable variants fast: